Skip to contentI
Innoviva, Inc.
I
INVAInnoviva, Inc. Q4 2024 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$91.81M$91.81Mderived+7.0% vs Q4 2023 Net Income$20.33M$20.33Mderived−67.0% vs Q4 2023 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Innoviva, Inc. · CIK 1080014 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$78,130,000— Operating Incomederived$43,139,000— Operating Cash Flowderived$59,239,000+78.1% Free Cash Flowderived$59,239,000+78.9% Margins · derivedGross margin85.1%
Operating margin47.0%
Net margin22.1%−49.5 pt vs Q4 2023
ended Dec 31, 2024 · filed Feb 26, 2025 · 57 d after period end